Modified fibonacci search

Journal of Clinical Oncology

Volumn 21, Issue 16, 2003, Pages 3177-

  Omura, George A ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

DRUG ADMINISTRATION; HUMAN; LETTER; MATHEMATICAL COMPUTING; PHASE 1 CLINICAL TRIAL;

ANTINEOPLASTIC AGENTS; CLINICAL TRIALS, PHASE I; DRUG ADMINISTRATION SCHEDULE; HUMANS; MATHEMATICAL COMPUTING;

EID: 0042914645     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2003.99.058     Document Type: Letter

References (8)

1. Eisenhauer EA, O'Dwyer PJ, Christian M, et al: Phase I clinical trial design in cancer drug development. J Clin Oncol 18: 684-692, 2000
2. Schneiderman MA: Mouse to man: Statistical problems in bringing a drug to clinical trial-Proceedings of the fifth Berkeley symposium on mathematical statistics and probability (vol IV). Berkeley, CA, University of California Press, 1967, pp 855-866
3. Wolff SN, Fer MF, McKay CM, et al: High dose VP-16-213 and autologous bone marrow transplantation for refractory malignancies: A phase I study. J Clin Oncol 1: 701-705, 1983
4. Livio M: The Golden Ratio: The Story of Phi, the World's Most Astonishing Number. New York, NY, Broadway Books, 2002
5. Bellman RE: Dynamic Programming. Princeton, NJ, Princeton University Press, 1957
6. Hansen HH, Selawry OS, Muggia FM, et al: Clinical studies with 1-(2-chloroethyl)-3- cyclohexyl-1-nitrosourea (NSC 79037). Cancer Res 31: 223-227, 1971
7. Goldsmith MA, Slavik M, Carter SK: Quantitative prediction of drug toxicity in humans from toxicology in small and large animals. Cancer Res 35: 1354-1364, 1975
8. Propper DJ, de Bono J, Saleem A, et al: Use of positron emission tomography in pharmacokinetic studies to investigate therapeutic advantage in a phase I study of 120-hour intravenous infusion XR5000. J Clin Oncol 21: 203-210, 2003